Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem, Inc. (ENZB)
:ENZB
Total Valuation
Enzo Biochem has a market cap or net worth of $25.67M. The enterprise value is ―.
Market Cap$25.67M
Enterprise Value―
Share Statistics
Enzo Biochem has 52,402,805 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,402,805
Owned by Insiders12.08%
Owned by Institutions0.08%
Financial Efficiency
Enzo Biochem’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count125
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Enzo Biochem is ―. Enzo Biochem’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Enzo Biochem had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Enzo Biochem pays an annual dividend of $0.1, resulting in a dividend yield of ―
Dividend Per Share$0.1
Dividend Yield―
Payout Ratio-24.45%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.72
52-Week Price Change-49.48%
50-Day Moving Average0.43
200-Day Moving Average0.81
Relative Strength Index (RSI)61.70
Average Volume (3m)555.41K
Important Dates
Enzo Biochem upcoming earnings date is Jun 16, 2025, TBA Not Confirmed.
Last Earnings DateMar 17, 2025
Next Earnings DateJun 16, 2025
Ex-Dividend DateNov 15, 2024
Financial Position
Enzo Biochem as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Enzo Biochem has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Enzo Biochem EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Enzo Biochem has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Enzo Biochem is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―